COVID-19 pneumonia: pathophysiology and management

L Gattinoni, S Gattarello, I Steinberg… - European …, 2021 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) pneumonia is an evolving disease. We will focus on
the development of its pathophysiologic characteristics over time, and how these time …

Respiratory indications for ECMO: focus on COVID-19

A Supady, A Combes, RP Barbaro, L Camporota… - Intensive Care …, 2022 - Springer
Extracorporeal membrane oxygenation (ECMO) is increasingly being used for patients with
severe respiratory failure and has received particular attention during the coronavirus …

Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia

CO Pickens, CA Gao, MJ Cuttica, SB Smith… - American journal of …, 2021 - atsjournals.org
Rationale: Current guidelines recommend patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected …

Clinical characteristics and outcomes of patients with COVID-19–associated acute respiratory distress syndrome who underwent lung transplant

C Kurihara, A Manerikar, M Querrey, C Felicelli… - Jama, 2022 - jamanetwork.com
Importance Lung transplantation is a potentially lifesaving treatment for patients who are
critically ill due to COVID-19–associated acute respiratory distress syndrome (ARDS), but …

Pathophysiology of coronavirus-19 disease acute lung injury

L Camporota, JN Cronin, M Busana… - Current opinion in …, 2022 - journals.lww.com
This review summarises the fundamental pathophysiological features of COVID-19 in the
context of the respiratory system. It provides an overview of the key clinical manifestations of …

[HTML][HTML] Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection

RJ Mylvaganam, JI Bailey, JI Sznajder… - European respiratory …, 2021 - Eur Respiratory Soc
Acute manifestations of SARS-CoV-2 infection continue to impact the lives of many across
the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30 …

[HTML][HTML] Post-COVID-19 pulmonary fibrosis

A Mohammadi, I Balan, S Yadav, WF Matos… - Cureus, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …

Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS …

KE Konopka, W Perry, T Huang, CF Farver… - …, 2021 - thelancet.com
Background There is increasing interest in persistent interstitial lung disease (ILD) following
resolution of acute COVID-19. No studies have yet reported findings in surgical lung …

Distinctive features of severe SARS-CoV-2 pneumonia

GRS Budinger, AV Misharin, KM Ridge… - The Journal of …, 2021 - Am Soc Clin Investig
The coronavirus disease 2019 (COVID-19) pandemic is among the most important public
health crises of our generation. Despite the promise of prevention offered by effective …

Lung transplantation for patients with COVID-19

CS King, H Mannem, J Kukreja, S Aryal, D Tang… - Chest, 2022 - Elsevier
The COVID-19 pandemic has caused acute lung injury in millions of individuals worldwide.
Some patients develop COVID-related acute respiratory distress syndrome (CARDS) and …